Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cervix carcinoma
|
283 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.040 | 1.000 | 4 | 2010 | 2017 | |||||
Malignant Neoplasms
|
1641 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.040 | 0.750 | 4 | 2014 | 2018 | |||||
Primary malignant neoplasm
|
1374 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.040 | 0.750 | 4 | 2014 | 2018 | |||||
cervical cancer
|
268 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.030 | 1.000 | 3 | 2010 | 2017 | |||||
Liver carcinoma
|
942 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.030 | 0.667 | 3 | 2012 | 2014 | |||||
Malignant tumor of cervix
|
245 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.030 | 1.000 | 3 | 2010 | 2017 | |||||
Squamous cell carcinoma of esophagus
|
329 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.020 | 1.000 | 2 | 2014 | 2018 | |||||
Adenocarcinoma
|
168 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Breast Carcinoma
|
2793 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Carcinogenesis
|
355 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.010 | 1.000 | 1 | 2013 | 2013 | |||||
Central neuroblastoma
|
231 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Cervical Intraepithelial Neoplasia
|
29 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Childhood Neuroblastoma
|
231 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Coronary heart disease
|
1178 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.010 | 1 | 2013 | 2013 | ||||||
Hepatitis B
|
519 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Hepatocarcinogenesis
|
24 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Malignant neoplasm of breast
|
3417 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Malignant neoplasm of stomach
|
615 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.010 | 1.000 | 1 | 2017 | 2017 | |||||
Mucocutaneous Lymph Node Syndrome
|
195 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.010 | 1 | 2018 | 2018 | ||||||
Myocardial Infarction
|
680 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.010 | 1.000 | 1 | 2014 | 2014 | |||||
Neuroblastoma
|
386 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Non-Small Cell Lung Carcinoma
|
712 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Squamous cell carcinoma
|
257 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.010 | 1.000 | 1 | 2018 | 2018 | |||||
Stomach Carcinoma
|
652 | 0.677 | 0.400 | 5 | 168768351 | intron variant | G/A | snv | 0.25 | 0.010 | 1.000 | 1 | 2017 | 2017 |